C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2011
03/15/2011	US7906297 Reagents for the detection of phosphorylated ATR kinase (Ser 428) and uses thereof
03/15/2011	US7906290 Antibody recognizing misfolded proteins that can be assigned specifically to one of the diseases
03/15/2011	US7906277 Compound and methods for diagnosis of tuberculosis
03/15/2011	US7906119 Antibodies against protective antigen
03/15/2011	US7906118 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
03/15/2011	US7906117 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
03/15/2011	US7906116 Methods for using and identifying modulators of Delta-like 4
03/15/2011	US7906115 Antitumor, anticancer agents; complexing of phosphatides and antibodies
03/15/2011	US7906104 Methods for detecting pancreatic beta-islet cells and diseases thereof
03/15/2011	CA2494698C Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
03/15/2011	CA2489123C Use of a clathrate modifier to promote passage of proteins during nanofiltration
03/15/2011	CA2452005C Inhibition of apoptosis process and improvement of cell performance
03/15/2011	CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/15/2011	CA2389302C Delivery of proteins across polar epithelial cell layers
03/15/2011	CA2380833C Proteins derived from white spot syndrome virus and uses thereof
03/15/2011	CA2374398C Immunoconjugates having high binding affinity
03/15/2011	CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
03/15/2011	CA2188422C Bifunctional protein, preparation and use
03/10/2011	WO2011029008A2 Synbodies to akt1
03/10/2011	WO2011028963A2 Immunogenic hiv composition
03/10/2011	WO2011028952A1 Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
03/10/2011	WO2011028921A1 Antibodies to disulfated heparin disaccharide in the diagnosis of neuropathy
03/10/2011	WO2011028811A2 Dual variable domain immunoglobulins and uses thereof
03/10/2011	WO2011028697A2 Uses of cd 116 expression level
03/10/2011	WO2011028683A1 Anti-gitr antibodies
03/10/2011	WO2011028390A1 Compositions and methods for potentiating interleukin-35
03/10/2011	WO2011027132A1 Clec14a inhibitors
03/10/2011	WO2011027129A1 Treatment of vasculoproliferative conditions
03/10/2011	WO2011026948A1 Stable formulations of polypeptides and uses thereof
03/10/2011	WO2011026945A1 Stable formulations of polypeptides and uses thereof
03/10/2011	WO2011026242A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor
03/10/2011	WO2011003622A8 Method for the production of variable domains
03/10/2011	WO2010127180A3 Dc-stamp antibodies
03/10/2011	WO2010126279A3 Cytokeratin 17-specific human antibody
03/10/2011	WO2010115995A3 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/10/2011	WO2010115094A3 Methods for determine atherosclerosis regression, plaque stabilization and cardiovascular risk
03/10/2011	US20110060131 Monospecific antibody and method of production using as antigen an isoform of the human fad synthetase
03/10/2011	US20110060130 Neutralizing human anti-igfr antibody
03/10/2011	US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
03/10/2011	US20110059890 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
03/10/2011	US20110059867 Functionalized polydiacetylene sensors
03/10/2011	US20110059524 Human cdr-grafted antibody and antibody fragment thereof
03/10/2011	US20110059522 Nucleic acids encoding a house dust mite allergen, der p iii, and uses thereof
03/10/2011	US20110059501 Protein Glycosylation
03/10/2011	US20110059488 Anti-MPL Antibodies
03/10/2011	US20110059484 Process for producing polypeptides
03/10/2011	US20110059472 Reagents and methods for detecting influenza virus proteins
03/10/2011	US20110059471 Antibody having an immune-enhancement function
03/10/2011	US20110059469 Anti-cldn6 antibody
03/10/2011	US20110059463 Serine and Threonine Phosphorylation Sites
03/10/2011	US20110059120 Glucan-based vaccines
03/10/2011	US20110059115 Antibody composition exhibiting cellular cytotoxicty due to glycosylation
03/10/2011	US20110059112 Anti-robo4 antibodies and uses therefor
03/10/2011	US20110059110 Antibody (11c7) anti nogo-a and its pharmaceutical use
03/10/2011	US20110059107 Antikine antibodies that bind to multiple cc chemokines
03/10/2011	US20110059105 Tie complex binding proteins
03/10/2011	US20110059104 Apo-2L receptor agonist and CPT-11 synergism
03/10/2011	US20110059101 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
03/10/2011	US20110059100 C/CLP Antagonists And Methods Of Use Thereof
03/10/2011	US20110059099 Treatment of idiopathic thrombocytopenic purpura
03/10/2011	US20110059098 Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof
03/10/2011	US20110059097 MFAP4 as a Marker For Regulatory Cells and Anti-Cancer Cells
03/10/2011	US20110059096 Targeting of Notch3 Receptor Function for Cancer Therapy
03/10/2011	US20110059095 High affinity human antibodies to human protease-activated receptor-2
03/10/2011	US20110059094 Antitumor effects of insulin-responsive dna binding protein-1 (irdbp-1)
03/10/2011	US20110059093 Use of an anti-tau ps422 antibody for the treatment of brain diseases
03/10/2011	US20110059092 Antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs
03/10/2011	US20110059091 Inhibitors of oncogenic isoforms and uses thereof
03/10/2011	US20110059090 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
03/10/2011	US20110059088 Protein involved in ovarian cancer
03/10/2011	US20110059087 Il-17 and il-23 antagonists and methods of using the same
03/10/2011	US20110059086 Espfu nucleic acids and proteins and uses thereof
03/10/2011	US20110059078 Anti-ifnar1 antibodies with reduced fc ligand affinity
03/10/2011	US20110059077 Humanized anti-human alpha 9-integrin antibody
03/10/2011	US20110059075 Aglycosylated immunoglobulin mutants
03/10/2011	US20110059073 Method for treating infectious disease using monoclonal antibodies
03/10/2011	US20110059072 Method for treating cancer using monoclonal antibodies
03/10/2011	US20110059071 Use of cd28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
03/10/2011	US20110059063 Antigen binding proteins that bind PAR-2
03/10/2011	US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins
03/10/2011	US20110059015 Vaccine
03/10/2011	US20110059011 Diagnosis and treatment of diseased and damaged tissue
03/10/2011	CA2810119A1 Clec14a inhibitors
03/10/2011	CA2780713A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor
03/10/2011	CA2772715A1 Mutant smoothened and methods of using the same
03/10/2011	CA2772653A1 Enhanced protein purification through a modified protein a elution
03/10/2011	CA2772628A1 Dual variable domain immunoglobulins and uses thereof
03/10/2011	CA2772613A1 Anti-gitr antibodies
03/10/2011	CA2772567A1 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
03/10/2011	CA2772032A1 Antibodies to disulfated heparin disaccharide in the diagnosis of neuropathy
03/10/2011	CA2771965A1 Treatment of vasculoproliferative conditions
03/09/2011	EP2293079A2 Use of precursors of enkephalins and/or their fragments in medical diagnostics
03/09/2011	EP2293069A2 Methods and compositions for the detection of cervical disease
03/09/2011	EP2292784A2 Enzymes having alpha amylase activity and methods of use thereof
03/09/2011	EP2292767A2 Polypepdides having DNA polymerase activity
03/09/2011	EP2292766A2 Polypeptides having DNA polymerase activity
03/09/2011	EP2292762A2 VMP-like sequences of pathogenic Borrelia species and strains
03/09/2011	EP2292761A1 Vascular adhesion molecules and modulation of their function
03/09/2011	EP2292760A2 Mammalian cytokines, receptors, related reagents and methods
03/09/2011	EP2292758A2 Uses of mammalian cytokine; related reagents

1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 1494